Onomondo's €100m deal leaves the cash split undisclosed
Aspirity's planned majority stake combines a seller exit with added backing. The parties have not separated purchase proceeds from capital for Onomondo.
K4invest / Latest news
Technology
Expert insights to improve your financial decisions
Samsung’s Helix commitment ties capital to supplier access
Six Samsung affiliates pledged $1 billion to Helix. The commitment adds capital and potential suppliers, while customer orders remain to be shown.
The AI buildout’s $10.3 trillion scenario hides a financing question
Brookings models a vast U.S. AI infrastructure cycle, not committed spending. Leases and project debt could move risk beyond tech-company balance sheets.
Deutsche Telekom’s AI call shift needs a resolution test
The telco’s AI chief reports more calls handled without staff. The missing measures are resolution, repeat contact and cost per solved case.
Qualcomm's agent commerce demo still needs three handoffs
The Qualcomm-Mastercard demo links devices to an authorized purchase. Merchant offers, consent and repeat use remain the commercial tests.
Tekever's valuation faces a two-stage delivery test
A first-close financing and an up-to-£400m UK programme support expansion, but neither figure is fully realized cash or revenue.
Nscale's convertible bridge leaves a capacity gap to close
The $3.36 billion financing has two funding dates. Nscale's SEC filing shows a wide gap between active capacity and total contracted value.
Akamai’s Anthropic contract runs on a cash clock
The $11.6 billion cloud commitment comes with early hardware spending and a conditional warrant. Realized cash flow will decide its value.
Muse’s app momentum must survive the checkout gate
Muse has attention and Meta’s distribution, but merchant access, repeat task completion and paid conversion are still unproven economic links.
Benford’s audit software faces the signature test
Benford raised €5m to combine an audit firm with its own software. The real test is repeatable quality and economics under professional responsibility.
Morphotonics has funding; optical yield is the next test
A €40m-plus round funds large-area optical equipment. Factory yield, customer acceptance and repeat deployments will determine its commercial weight.
Tandem’s clinic ambition puts saved minutes under an economic microscope
The $100 million round funds a broader clinical workflow ambition. Turning less paperwork into durable value requires evidence beyond the financing.